Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens
about
Recent advances in orally administered cell-specific nanotherapeutics for inflammatory bowel diseaseEnhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosaMechanisms of Natural Tolerance in the IntestineA preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection.Recent advances in inflammatory bowel disease.Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel diseaseHuman colonic intraepithelial lymphocytes suppress in vitro immunoglobulin synthesis by autologous peripheral blood lymphocytes and lamina propria lymphocytes.Gliadin induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies with coeliac disease mucosaExpression of CD45RO on circulating CD19+ B-cells in Crohn's disease.Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resectionPlasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin.Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity.Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.Immunoregulation in the gut: success and failures in human disease.Response of human intestinal lamina propria T lymphocytes to interleukin 12: additive effects of interleukin 15 and 7Interleukin 16 expression and phenotype of interleukin 16 producing cells in Crohn's disease.Cytokines in inflammatory bowel disease.Increased mucosal tumour necrosis factor alpha production in Crohn's disease can be downregulated ex vivo by probiotic bacteria.Differences in immunophenotyping of mucosal lymphocytes between ulcerative colitis and Crohn's disease.Bone turnover and nutritional status in Crohn's disease: relationship to circulating mononuclear cell function and response to fish oil and antioxidants.Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studiesSoluble interleukin-2 receptors in ulcerative colitisThe role of cytokines in inflammatory bowel disease.Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease.Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis.Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease.Human intestinal lamina propria lymphocytes are naturally permissive to HIV-1 infection.Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease.Shigella infection induces cellular activation of T and B cells and distinct species-related changes in peripheral blood lymphocyte subsets during the course of the disease.Potential role of superantigen induced activation of cell mediated immune mechanisms in the pathogenesis of Crohn's disease.Activation antigens on colonic T cells in inflammatory bowel disease: effects of IL-10.Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis.Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?Autoimmunity in ulcerative colitis (UC): a predominant colonic mucosal B cell response against human tropomyosin isoform 5.Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis.Coexpression of CD4 and CD8 on peripheral blood T cells and lamina propria T cells in inflammatory bowel disease by two colour immunofluorescence and flow cytometric analysis.Inability of normal human intestinal macrophages to form multinucleated giant cells in response to cytokines.Increased in vitro release of soluble interleukin 2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease.Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon gamma inducers.
P2860
Q28073219-B60A864B-2A70-4DBD-8E0D-25E3DB7E10FBQ28476816-B0F7D962-02EB-449E-B2FE-5580F007D2F5Q29031968-B3827230-391E-4D04-B1BF-79817BD539B6Q33853988-2BAE6636-808B-426D-9074-E06C897D2983Q34188405-CF3F03DA-21CE-40DD-B90D-D985603D5A7BQ34375240-E75C0590-52E8-4EF3-96D2-0716C0E9ECB4Q34375605-F582C2DE-8AAD-41C2-BD8D-9DB15AE4C13DQ34376007-8DABF066-99F9-4795-A195-5605FC9A2641Q34377782-9D668A73-F3BB-41A4-985D-8DD42818042FQ34380598-AE60BABB-48F3-42DF-A7DD-C1E925A9D4A3Q34392462-428AD0FD-03C4-439E-85E2-EBD48AF5F848Q34392919-7A2B8E29-BE9D-4CA7-A50A-30C483FB4D27Q34393256-045FF9A9-1F18-4A3A-B4CF-AB9D83E23BEDQ34395157-4F70B826-E763-4840-9DEC-F3C9BA879331Q34601009-CF108596-50E1-4571-963E-3B107528A3F5Q35353309-FD4B0976-610D-43F1-8CC5-7C57B4B1C300Q35366019-3B8A1089-11EE-4AE5-A4C2-143D7672BE8FQ35556914-0F9C7F29-535E-4C60-8E00-664301A47C3FQ35595154-2E6B0C99-1DBB-46A7-B061-5B788EC899DAQ35938520-1900E1D2-F7C9-40E5-B4B5-AE6FA7DE0877Q36165341-652B1013-8CEC-4FDC-A459-385EFD42849CQ36620188-E24BFAD4-3215-4BFC-999B-C03448D4D73BQ36627074-D0135E10-0930-4D06-84CC-BA3AB7F240ADQ37160344-EBB607C9-40AD-4390-865F-1E9279B4F5D2Q37359714-95369CF3-DAF4-4333-9C2D-4A6158F6418CQ37361932-829FC7A8-4E03-46A8-9453-E5ED5ED5A07DQ38049367-E2E77BCF-717F-45D8-A4A3-2B25A452BC30Q39160304-880B7557-317E-47CC-93D7-9ADE9CA5E8C8Q39792621-1DED02C3-46B1-4699-A5D1-304E23FFFA48Q39822623-648036F5-CDC8-4344-AFDB-289143F98B5BQ40398650-5D7EAB37-77F9-4A0D-B1C5-4AC4D8DE090AQ40447708-D58BA6B9-2191-492D-8D0F-90500633113CQ40640408-128EB4A6-FE1C-472A-870E-40C4BA9C1560Q40690714-F2130391-A140-48A5-A6EF-9EA7C37EBA2CQ41759380-FC2DAFDE-10DE-4FF9-A867-6737FB72DBBCQ41761096-321598FB-1068-4203-9A0C-D8EB913C03B0Q41849591-00B64298-168A-4AE4-8813-9D12201E12C5Q41937050-0C30DFB9-2C53-4BAB-B509-BAF94A6E56F1Q43212555-C81DF4E5-0C2A-44A6-901C-A8537F4115F6Q43220696-E7BC0667-189B-409D-951E-C78D253E4200
P2860
Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Activation of peripheral blood ...... n of early activation antigens
@ast
Activation of peripheral blood ...... n of early activation antigens
@en
Activation of peripheral blood ...... n of early activation antigens
@nl
type
label
Activation of peripheral blood ...... n of early activation antigens
@ast
Activation of peripheral blood ...... n of early activation antigens
@en
Activation of peripheral blood ...... n of early activation antigens
@nl
prefLabel
Activation of peripheral blood ...... n of early activation antigens
@ast
Activation of peripheral blood ...... n of early activation antigens
@en
Activation of peripheral blood ...... n of early activation antigens
@nl
P2093
P2860
P356
P1433
P1476
Activation of peripheral blood ...... n of early activation antigens
@en
P2093
P2860
P304
P356
10.1136/GUT.28.6.745
P407
P577
1987-06-01T00:00:00Z